Invariant NKT Cells and Tolerance
- 1 January 2007
- journal article
- review article
- Published by Taylor & Francis in International Reviews of Immunology
- Vol. 26 (1-2) , 95-119
- https://doi.org/10.1080/08830180601070195
Abstract
Invariant natural killer T (iNKT) cells are innate cells that can bias an immune response toward inflammation or toward a negative regulatory response. iNKT cells can produce cytokines immediately on exposure to activating signals, but the role of iNKT cells in the differentiation of T regulatory (Treg) cells and peripheral tolerance was elucidated only within the past decade. The purpose of this review is to outline the current knowledge of how iNKT cells function in various tolerance paradigms. The roles of iNKT cell in anterior chamber-associated immune deviation (ACAID), oral tolerance, other tolerance systems, and autoimmune diseases is discussed.Keywords
This publication has 125 references indexed in Scilit:
- IL-10–producing macrophages preferentially clear early apoptotic cellsBlood, 2006
- NKT cells play critical roles in the induction of oral tolerance by inducing regulatory T cells producing IL‐10 and transforming growth factor β, and by clonally deleting antigen‐specific T cellsImmunology, 2006
- A Privileged View of NKT Cells and Peripheral Tolerance Through the EyeOcular Immunology and Inflammation, 2005
- CD1d-dependent macrophage-mediated clearance of Pseudomonas aeruginosa from lungNature Medicine, 2002
- CD1d on antigen-transporting APC and splenic marginal zone B cells promotes NKT cell-dependent toleranceEuropean Journal of Immunology, 2002
- Mouse and human dendritic cell subtypesNature Reviews Immunology, 2002
- Bone Marrow NK1.1− and NK1.1+ T Cells Reciprocally Regulate Acute Graft versus Host DiseaseThe Journal of Experimental Medicine, 1999
- Effect of interleukin‐10 on dendritic cell maturation and functionEuropean Journal of Immunology, 1997
- Early quantitative and functional deficiency of NK1+‐like thymocytes in the NOD mouseEuropean Journal of Immunology, 1996
- Therapy with monoclonal antibodies by elimination of T-cell subsets in vivoNature, 1984